Pharmacophore and structure-based drug design, molecular dynamics and admet/tox studies to design novel potential pad4 inhibitors

被引:29
|
作者
Barcellos, Mariana P. [1 ]
Santos, Cleydson B. R. [2 ]
Federico, Leonardo B. [1 ]
de Almeida, Paulo Fernando [3 ]
de Paula da Silva, Carlos H. T. [1 ]
Taft, Carlton A. [4 ]
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Av Cafe S-N, BR-14040903 Ribeirao Preto, SP, Brazil
[2] Univ Fed Amapa, Lab Modelagem & Quim Comp, Rod JK Km 2, BR-68902280 Macapa, AP, Brazil
[3] Univ Fed Bahia, Inst Ciencias Saude, Dept Ciencias Biointeracao, Av Reitor Miguel Calmon S-N, BR-40300100 Salvador, BA, Brazil
[4] CBPF, Rua Dr Xavier Sigaud 150, BR-22290180 Rio De Janeiro, RJ, Brazil
来源
关键词
structure-based drug design; pharmacophore; molecular dynamics; Pad4; ADME/Tox; INTERACTION FIELD; IDENTIFICATION; PREDICTIONS; DOCKING;
D O I
10.1080/07391102.2018.1444511
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have used docking (GLIDE), pharmacophore modeling (Discovery Studio), long trajectory molecular dynamics (Discovery Studio) and ADMET/Tox (QikProp and DEREK) to investigate PAD4 in order to determine potential novel inhibitors and hits. We have carried out virtual screening in the ZINC natural compounds database. Pharmacokinetics and Toxicity of the best hits were assessed using databases implemented in softwares that create models based on chemical structures taking into account consideration about the toxicophoric groups. A wide variety of pharmaceutical relevant properties are determined in order to make decisions about molecular suitability. After screening and analysis, the 6 most promising PAD4 inhibitors are suggested, with strong interactions (pi-stacking, hydrogen bonds, hydrophobic contacts) and suitable pharmacotherapeutic profile as well.
引用
收藏
页码:966 / 981
页数:16
相关论文
共 50 条
  • [1] ADMET/Tox informatics: Adding innovation to structure-based drug design - Preface
    Bursi, R
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (11)
  • [2] Exploration of potential inhibitors for tuberculosis via structure-based drug design, molecular docking, and molecular dynamics simulation studies
    Rajasekhar, Sreerama
    Karuppasamy, Ramanathan
    Chanda, Kaushik
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2021, 42 (24) : 1736 - 1749
  • [3] Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity
    Zhou, Yunjiang
    Di, Bin
    Niu, Miao-Miao
    [J]. MOLECULES, 2019, 24 (17):
  • [4] Structure-based drug design for protein arginine deiminase Type IV (PAD4) receptor: Chemoinformatics approach
    Santos, Cleydson B. R.
    Cruz, Jorddy N.
    Federico, Leonardo B.
    Mali, Suraj N.
    Kimani, Njogu M.
    Lobato, Cleison C.
    Silva, Rai C.
    Bittencourt, Jose A. H. M.
    Bastos, Ruan S.
    da Costa, Renato A.
    da Silva, Carlos H. T. P.
    [J]. CHEMICAL PHYSICS IMPACT, 2024, 8
  • [5] Structure-based drug design, molecular dynamics simulation, ADMET, and quantum chemical studies of some thiazolinones targeting influenza neuraminidase
    Abdullahi, Mustapha
    Uzairu, Adamu
    Shallangwa, Gideon Adamu
    Mamza, Paul Andrew
    Ibrahim, Muhammad Tukur
    Ahmad, Iqrar
    Patel, Harun
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (23): : 13829 - 13843
  • [6] Structure-Based Drug Design Studies on a Series of Aldolase Inhibitors
    Ferreira, Leonardo G.
    dos Santos, Ricardo N.
    Andricopulo, Adriano D.
    [J]. JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2013, 24 (02) : 201 - 211
  • [7] Molecular recognition studies to advance structure-based drug design
    Diederich, Francois
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [8] Discovery of novel α-amylase inhibitors using structure-based drug design
    Jamil Al-Asri
    Gerhard Wolber
    [J]. Journal of Cheminformatics, 6 (Suppl 1)
  • [9] Advances in structure-based drug design of novel bacterial topoisomerase inhibitors
    Widdowson, Katherine
    Hennessy, Alan
    [J]. FUTURE MEDICINAL CHEMISTRY, 2010, 2 (11) : 1619 - 1622
  • [10] Identification of novel PAD4 inhibitors based on a pharmacophore model derived from transition state coordinates
    Wei, Yu
    Liu, Ruihua
    Liu, Cui
    Jin, Jin
    Li, Dongmei
    Lin, Jianping
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2017, 72 : 88 - 95